NCT02301156 · Interventional trial
Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)
Overall registry status Completed
Phase 3
Conditions Chronic Lymphocytic Leukemia
Delaware Valley sites
- TG Therapeutics Investigational Trial Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory